Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent

被引:89
作者
Martinet, L [1 ]
GuardiolaLemaitre, B [1 ]
Mocaer, E [1 ]
机构
[1] INST RECH INT SERVIER, F-92415 COURBEVOIE, FRANCE
关键词
circadian rhythm; entrainment; dose-response; S-20098; melatonin; ipsapirone; rat;
D O I
10.1016/0091-3057(95)02221-X
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The present study determined first the dose-response (0.5 to 10 mg . kg(-1)) to daily oral administration of S-20098. a melatonin agonist, in entraining circadian rhythms of rats free-running in constant darkness; second, the relation between entrainment and the plasma concentration of S-20098. Finally, responses to 8 mg . kg(-1) of S-20098 were compared with those obtained with the same dose of melatonin and ipsapirone. Responses were classified as negative, transient, or true entrainment. The data indicated a clear dose-dependent response from 2.5 to 10 mg . kg(-1) of S-20098 with an EDS, of 5.7 mg . kg(-1) for true entrainment and a clear relation between entrainment and the plasma concentration of S-20098. S-20098 was as effective as melatonin to entrain free-running rhythms. Ipsapirone was ineffective in our experimental conditions.
引用
收藏
页码:713 / 718
页数:6
相关论文
共 22 条
[11]   MELATONIN SHIFTS HUMAN CIRCADIAN-RHYTHMS ACCORDING TO A PHASE RESPONSE CURVE [J].
LEWY, AJ ;
AHMED, S ;
JACKSON, JML ;
SACK, RL .
CHRONOBIOLOGY INTERNATIONAL, 1992, 9 (05) :380-392
[12]  
MASON R, 1986, J PHYSIOL-LONDON, V377, P1
[13]  
MASON R, 1993, BRIT J PHARMACOL, V108, pP32
[14]   MELATONIN DIRECTLY RESETS THE RAT SUPRACHIASMATIC CIRCADIAN CLOCK INVITRO [J].
MCARTHUR, AJ ;
GILLETTE, MU ;
PROSSER, RA .
BRAIN RESEARCH, 1991, 565 (01) :158-161
[15]   A SEROTONIN AGONIST PHASE-SHIFTS THE CIRCADIAN CLOCK IN THE SUPRACHIASMATIC NUCLEI INVITRO [J].
PROSSER, RA ;
MILLER, JD ;
HELLER, HC .
BRAIN RESEARCH, 1990, 534 (1-2) :336-339
[16]  
REDMAN JR, 1993, INT CONGR SER, V1017, P127
[17]  
REDMAN JR, 1983, SCIENCE, V219, P1081
[18]  
REDMAN JR, 1994, NEUROPSYCHOPHARMACOL, V10, pS173
[19]  
Van Reeth O., 1994, Society for Neuroscience Abstracts, V20, P1440
[20]  
WEAVER DR, 1989, J NEUROSCI, V9, P2581